1. Home
  2. ALLO vs BMM Comparison

ALLO vs BMM Comparison

Compare ALLO & BMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.06

Market Cap

707.6M

Sector

Health Care

ML Signal

HOLD

BMM

Blue Moon Metals Inc. Common Shares

N/A

Current Price

$6.01

Market Cap

654.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLO
BMM
Founded
2017
2007
Country
United States
Canada
Employees
N/A
27
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.6M
654.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
BMM
Price
$2.06
$6.01
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$8.35
N/A
AVG Volume (30 Days)
7.8M
112.7K
Earning Date
05-07-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
34.09
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$142,416.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$3.47
52 Week High
$4.46
$8.63

Technical Indicators

Market Signals
Indicator
ALLO
BMM
Relative Strength Index (RSI) 52.33 38.71
Support Level $1.85 $4.79
Resistance Level $2.36 $6.56
Average True Range (ATR) 0.13 0.56
MACD 0.03 -0.09
Stochastic Oscillator 74.12 2.73

Price Performance

Historical Comparison
ALLO
BMM

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.

Share on Social Networks: